InvestSMART

Allegra Medical Technologies Limited (ASX: AMT) - Announcements

DELISTED - Current share price for AMT : $0.029

ASX company news and announcements for Allegra Medical Technologies Limited (AMT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Allegra Medical Technologies Limited (AMT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Allegra Medical Technologies Limited (AMT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Allegra Medical Technologies Limited (AMT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- ASDM Expands Product Portfolio 16 Feb 2012 12:22PM $0.220 $0.029 fallen by 86.82%
- ASDM enters the $250M Australian Spinal Market 20 Sep 2011 9:01AM $0.150 $0.029 fallen by 80.67%
- Preliminary Final Report 31 Aug 2011 6:35PM $0.150 $0.029 fallen by 80.67%
- Signs Commercial Arrangement with Surgeon Group 4 Mar 2011 9:12AM $0.295 $0.029 fallen by 90.17%
- Half Yearly Report and Accounts 28 Feb 2011 6:25PM $0.300 $0.029 fallen by 90.33%
- ASDM Completes Strategic Review 16 Feb 2011 2:39PM $0.300 $0.029 fallen by 90.33%
- Positive Interim Results - PAD Clinical Trial 6 Dec 2010 11:09AM $0.345 $0.029 fallen by 91.59%
- International and Domestic Sales Growth 15 Nov 2010 1:39PM $0.400 $0.029 fallen by 92.75%
- New Distribution Agreement Broadens Market 4 Nov 2010 8:26AM $0.400 $0.029 fallen by 92.75%
- New Agreement for Substantial Growth in Sales and Profit 20 Oct 2010 10:12AM $0.400 $0.029 fallen by 92.75%
- Major New Revenue Opportunties 20 Sep 2010 9:57AM $0.360 $0.029 fallen by 91.94%
- Preliminary Final Report 31 Aug 2010 4:31PM $0.345 $0.029 fallen by 91.59%
- ASDM Signs Landmark PAD Licensing Deal 6 Jul 2010 10:06AM $0.420 $0.029 fallen by 93.10%
- First PAD Patient Discharged after Successful Treatment 4 Jun 2010 10:11AM $0.350 $0.029 fallen by 91.71%
- ASDM Establishes Direct Presence in Europe 19 May 2010 4:42PM $0.420 $0.029 fallen by 93.10%
- Major Trial for World-first Limb Saving Device Gets Go-ahead 9 Apr 2010 12:11PM $0.500 $0.029 fallen by 94.20%
- FDA Registration for Posterior Stabilised Knee 1 Mar 2010 10:28AM $0.520 $0.029 fallen by 94.42%
- Half Yearly Report and Accounts 22 Feb 2010 10:46AM $0.540 $0.029 fallen by 94.63%
- First Sales into Continental Europe 2 Dec 2009 10:53AM $0.590 $0.029 fallen by 95.08%
- Surgical device sold to US Multi-national 29 Oct 2009 9:15AM $0.600 $0.029 fallen by 95.17%
- Preliminary Final Report 26 Aug 2009 2:26PM $0.480 $0.029 fallen by 93.96%
- PAD Granted TGA Approval 10 Aug 2009 10:21AM $0.310 $0.029 fallen by 90.65%
- Appendix 4D - Results Announcement 25 Feb 2009 4:47PM $0.350 $0.029 fallen by 91.71%
- Business Update 29 Oct 2008 12:03PM n/a $0.029 n/a
- Preliminary Final Report 20 Aug 2008 2:13PM n/a $0.029 n/a

276 - 300 of 306 results

Page 12 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.